A lot of evidence suggests that Annexin A2 may be a promising therapeutic target for cancer treatment (Chen et al., 2015; Staquicini et al., 2017; Kesavan et al., 2010; Wang et al., 2012). The gene discussed is ANXA2; the disease is cancer.